Click to see our news releases about special projects and other announcements.Read More
Journalists: We are at your service. Please contact us with your request.Connect
ISB researchers are on the front lines to understand and treat COVID-19. We have partnered with Swedish Medical Center, Stanford University, Adaptive Biotechnologies, IsoPlexis, and Metabolon — with generous initial support from the MJ Murdock Charitable Trust and the Wilke Family Foundation — to launch a study of Seattle patients who have contracted COVID-19.
Researchers at ISB reported a novel method, Path-seq, to profile expression of all MTB genes within infected mice. This study presents the most comprehensive transcriptome profiling of MTB from in vivo infection and a major technical advancement for studying any host-pathogen interaction.